Clinical Trial Update: Tapentadol (CG5503) [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial of tapentadol for knee osteoarthritis, with results posted in April 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Osteoarthritis, Knee, Pain | Phase 3 | Status: COMPLETED | Results posted: 2010-04-23